OMG, that makes absolutely no sense to me given Lynas's profitability is founded on the disparity between Chinese domestic & FOB pricing. Do you honestly believe the LAMP would be profitable at China domestic, or that China would pay a premium at a time when they are shutting domestic producers because of overproduction? That's fantasy IMO. China would probably buy some Dy, Eu & Tb but these are the elements that Lynas should have little problem capturing ROW premiums and most likely the bulk of these are contracted to Rhodia for the next 10 years and the 20tpa Dy certainly won't be a problem.
Lynas's achilles heel is Ce, 50% of production from CLD, low value, greatest permanent demand destruction and China sure as hell doesn't need any. Apart from currently being a loss maker the ongoing impact of a good portion of Ce reporting to inventory will be a big drag on profitability. Moly is at least being proactive looking to develop a water filtration market - sure Lynas will be watching closely.
Lynas's strengths lie in a balanced suite, their ability to drive CoP down across the existing LT contracts and value add either thru meeting customer specs or moving downstream, not trying to sell coal to Newcastle.
That is the antithesis of the entire ROW RE story.
- Forums
- ASX - By Stock
- LYC
- aussie $ collapsing = rising ree price
aussie $ collapsing = rising ree price, page-20
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.38 |
Change
-0.025(0.39%) |
Mkt cap ! $5.954B |
Open | High | Low | Value | Volume |
$6.46 | $6.47 | $6.36 | $13.11M | 2.051M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 16885 | $6.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.38 | 47239 | 68 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 22996 | 6.370 |
38 | 36191 | 6.360 |
19 | 32383 | 6.350 |
11 | 32280 | 6.340 |
9 | 81787 | 6.330 |
Price($) | Vol. | No. |
---|---|---|
6.380 | 46358 | 62 |
6.390 | 39695 | 23 |
6.400 | 48185 | 25 |
6.410 | 25982 | 13 |
6.420 | 89774 | 13 |
Last trade - 14.36pm 15/07/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online